GSK3B and depressive symptom measurement: In a study of unipolar depressive patients, Tsai et al. (21) reported that structural abnormalities on MRI may be associated with the response to serotonin-reuptake inhibitors at 4 weeks and 3 SNPS in GSK-3β gene regions (15 SNPS detected).